1088 related articles for article (PubMed ID: 3772910)
1. Atherosclerotic risk factors in cardiovascular disease.
LaRosa JC
J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
[TBL] [Abstract][Full Text] [Related]
2. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
Bakir R; Hilliquin P
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of oral contraceptives: a review.
Stubblefield PG
Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
[TBL] [Abstract][Full Text] [Related]
6. [Oral contraception and carbohydrate metabolism: III--practical implications].
Hilal M
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):59-62. PubMed ID: 12341242
[TBL] [Abstract][Full Text] [Related]
7. Pill formulations and their effect on lipid and carbohydrate metabolism.
Brooks PG
J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral contraceptives on lipid metabolism.
Krauss RM
J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
[TBL] [Abstract][Full Text] [Related]
9. Women, lipoproteins and cardiovascular disease risk.
LaRosa JC
Can J Cardiol; 1990 May; 6 Suppl B():23B-29B. PubMed ID: 2188715
[TBL] [Abstract][Full Text] [Related]
10. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
Boyet F
Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
[TBL] [Abstract][Full Text] [Related]
11. [Oral contraception, glucid metabolism and monitoring criteria].
Gaspard U
Contracept Fertil Sex (Paris); 1988 Feb; 16(2):113-8. PubMed ID: 12342000
[TBL] [Abstract][Full Text] [Related]
12. [Oral contraceptives and metabolic changes].
Lara Ricalde R; Aznar Ramos R
Ginecol Obstet Mex; 1986 Aug; 54():212-5. PubMed ID: 3781292
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives and coronary heart disease.
Wynn V
J Reprod Med; 1991 Mar; 36(3 Suppl):219-25. PubMed ID: 2046075
[TBL] [Abstract][Full Text] [Related]
14. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy.
Burkman RT
Fertil Steril; 1988 May; 49(5 Suppl 2):39S-50S. PubMed ID: 3282934
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives and lipoprotein metabolism.
Tikkanen MJ; Nikkilä EA
J Reprod Med; 1986 Sep; 31(9 Suppl):898-905. PubMed ID: 3772909
[TBL] [Abstract][Full Text] [Related]
16. [Women and ischemic cardiopathy].
Assmann G; Davignon J; Fernández Cruz A; Gotto AM; Jacotot B; Lewis B; Paoletti R
Rev Clin Esp; 1989 Oct; 185(6):308-15. PubMed ID: 2695994
[TBL] [Abstract][Full Text] [Related]
17. [Metabolic risks of oral contraception].
Monier L
Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
[TBL] [Abstract][Full Text] [Related]
18. The metabolic impact of oral contraceptives.
Krauss RM; Burkman RT
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
[TBL] [Abstract][Full Text] [Related]
19. [Metabolic impact of current estrogen-progestins and cardiovascular consequences].
Gaspard U; Lambotte R
Bull Mem Acad R Med Belg; 1991; 146(8-10):334-42; discussion 342-5. PubMed ID: 1815814
[TBL] [Abstract][Full Text] [Related]
20. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
Kay CR
Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
